Promising Fertility Rate Is Escalating Demand for Preimplantation Genetic Diagnosis Market
Preimplantation Genetic Diagnosis is offering to help those
that aren't sure if they can have children of their own or if they will suffer
from certain medical issues in the future. Pregnancy and Fertility are two
other reasons why this test can be offered. The procedure is done when the
couple is preparing for conception by checking for any irregularities on an
ultrasound. The genetic information from the unaffected parents and the
affected eggs are compared to determine if a genetic problem exists with the
egg of one of the partners.
The growing number of fertility clinics around the globe
coupled with the advancement in the field of genetic analysis is driving the
growth of Preimplantation Genetic Diagnosis Market. The increasing need for
early detection of chromosomal abnormalities in the fetus is another major
factor fueling the growth of Preimplantation
Genetic Diagnosis Market. The advent of next-generation sequencing (NGS) is also
contributing to the market growth. Furthermore, the growing prevalence of
gene-related disorders is further anticipated to augment the growth of Preimplantation
Genetic Diagnosis Market. Additionally, growing awareness regarding genetic diagnosis
of a specific gene mutation among healthcare workers is again anticipated to
foster market growth. Also, increasing maternal age and growing incidence of
aneuploidy is expected to uplift the market growth in the near future.
From the geographical point of view, North America is
expected to gain significant growth over the forecast period and this is
attributed to the high incidence of the gene-related disorder in the region.
According to the U.S. Department of Health and Human Services, about 1 in
200,000 people in the United States are born with syndrome A each year. Around
1 in 100,000 people in the United States have syndrome A at the present time.
Key Developments:
1. In October 2019, PerkinElmer, Inc., a global provider of
innovating for a healthier world, introduced it's PG-Seq™ Rapid Non-Invasive Preimplantation
Genetic Diagnosis for Aneuploidy (PGT-A) kit. This solution tests spent embryo
culture media for chromosomal abnormalities during in vitro fertilization (IVF)
treatment.
2. In October 2018, Vitrolife AB (publ) has entered into a
License and Commercialisation Agreement with Illumina, Inc., which provides
Vitrolife with exclusive distribution, development, and commercialization
rights to Illumina’s Preimplantation Genetic Diagnosis business for IVF in EMEA
and Americas.
3. In July 2020, Chromosome Medicina Genômica, powered by
GeneOne, enter into a partnership with Genomic Prediction and Diagnostics da
America (DASA), to introduce LifeView™ PGT-P to Brazil.
Preimplantation Genetic Diagnosis, Preimplantation Genetic
Diagnosis Market, Market Research Report, Preimplantation Genetic Diagnosis
Market Trends, Preimplantation Genetic Diagnosis Market Forecast,
Preimplantation Genetic Diagnosis Market Size, Preimplantation Genetic
Diagnosis Market Analysis
Comments
Post a Comment